Bactericidal activity in cerebrospinal fluid by treating meningitis caused by Stomatococcus mucilaginosus with rifampicin, cefotaxime and vancomycin in a neutropenic child.
Skogen
P G
PG
Department of Pediatrics, University Hospital of Trondheim, Norway.
Kolmannskog
S
S
Bergh
K
K
D000900:Anti-Bacterial Agents / Q000134:cerebrospinal fluid* / Q000627:therapeutic use*; D002439:Cefotaxime / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D002675:Child, Preschool; D016908:Gram-Positive Bacterial Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D008297:Male; D016920:Meningitis, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D008835:Micrococcaceae / Q000187:drug effects*; D009503:Neutropenia / Q000150:complications*; D012293:Rifampin / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D014640:Vancomycin / Q000134:cerebrospinal fluid / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014640:Vancomycin; D002439:Cefotaxime; D012293:Rifampin